Biobook Launches Beta Version of TMPCONNECT, a Platform for Korean Life Science Startups and Global Pharmaceutical Companies

Biobook has announced the launch of the beta version of TMPCONNECT, an online matching service that enables​ real-time communication between Korean life science startups and global pharmaceutical companies and venture ‍capitals.

TMPCONNECT provides a comprehensive database of approximately 500 domestic bio healthcare-related companies, 2,000 overseas venture capitals, and 300 big pharma and small and medium-sized overseas pharmaceutical companies. The service is set to launch​ in earnest within the year, allowing companies ‍and investors to search and match ‌information with each other.

The platform also features a‍ communication channel for two-way communication between ‍startups and investors, as well as a customized information provision service that provides ⁢relevant information based on specified keywords in areas of interest.

Biobook ​is actively ‍promoting TMPCONNECT to overseas pharmaceutical companies and venture capitalists in the U.S.⁣ and Europe.

To celebrate the launch ⁢of the beta version, the service will be available for free until October.⁢ Users ⁤can access the⁢ site, enter their company name, email, and contact information, and request account creation. The service page is provided in English, and some company information will not be disclosed until the paid version is released.

Hong Soon-jae, CEO of⁣ Biobook, expressed his ambition, saying, “We will continue to promote Korea’s potential in various fields such as new drug development, digital healthcare, and diagnostic devices to the world,⁣ and collect opinions from⁣ investors to lead to technology development tailored to their needs, serving as a virtuous cycle link.”